Skip to Main Content

Author Details

Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
1999
239
37
PMIDPaper TitleJournal TitlePublished Year
37931278Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation.Can Urol Assoc J2024
36250946Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index Threshold.J Urol2023
37747733APPRAISE-AI Tool for Quantitative Evaluation of AI Studies for Clinical Decision Support.JAMA Netw Open2023
37549345Existing trends and applications of artificial intelligence in urothelial cancer A scoping review.Can Urol Assoc J2023
37730609Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.Radiat Oncol2023
35700531Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy.Arch Pathol Lab Med2023
37187202Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Lancet Oncol2023
37439809Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.Clin Cancer Res2023
37103562Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.Urol Pract2023
37005214Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers.Eur Urol Oncol2023
37096584Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline.J Urol2023
36473475Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer A pairwise meta-analysis of outcomes and a network meta-analysis of complications.Can Urol Assoc J2023
36774434Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses.Ann Surg Oncol2023
36639336Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance.Urol Oncol2023
33305701Repurposing of genistein as anti-sickling agent: elucidation by multi spectroscopic, thermophoresis, and molecular modeling techniques.J Biomol Struct Dyn2022
35507051Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.Eur Radiol2022
35703460Association Between Surgeon and Anesthesiologist Sex Discordance and Postoperative Outcomes: A Population-based Cohort Study.Ann Surg2022
35754788Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue.Prostate Cancer2022
35393232The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.Urol Oncol2022
35813250A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.Eur Urol Open Sci2022
35621292Androgen deprivation therapy for prostate cancer: Prescribing behaviors and preferences among urologists.Can Urol Assoc J2022
36031465Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.Int J Radiat Oncol Biol Phys2022
33642229Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.Urol Oncol2022
35074179The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes.Pathology2022
34941486The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy.Can Urol Assoc J2022
35135701Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeons.Urol Oncol2022
35195435Diagnostic Accuracy of MRI in Local Staging (T Category) of Penile Cancer and the Value of Artificial Erection: A Systematic Review and Meta-Analysis.AJR Am J Roentgenol2022
34674366Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness study.BJU Int2022
34464253Optimizing the management of patients with small renal masses in a Canadian context: A Markov decision-analysis model.Can Urol Assoc J2022
34547923Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level.J Urol2022
34812723Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model.Can Urol Assoc J2022
32424261Association between metformin medication, genetic variation and prostate cancer risk.Prostate Cancer Prostatic Dis2021
33685838Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.Eur Urol2021
33599318Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.Prostate2021
33592224A Population-based Study Comparing Outcomes for Patients With Metastatic Castrate Resistant Prostate Cancer Treated by Urologists or Medical Oncologists With First Line Abiraterone Acetate or Enzalutamide.Urology2021
33660142Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer : In response to: Dirk Böhmer and Arne Grün. Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer.Curr Oncol Rep2021
35099374Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.Can Urol Assoc J2021
34851968Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.PLoS One2021
34878794A Microcolumn DC Graphene Sensor for Rapid, Sensitive, and Universal Chemical Vapor Detection.Nano Lett2021
34665714Salvage lymph node dissection for prostate-specific membrane antigen (PSMA) positron emission tomography (PET)-identified oligometastatic disease.Can Urol Assoc J2021
33938798Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.Can Urol Assoc J2021
34175150Re: Radical Cystectomy Against Intravesical BCG for High-risk High-grade Nonmuscle Invasive Bladder Cancer: Results from the Randomized Controlled BRAVO-feasibility Study.Eur Urol2021
34032510Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.Radiology2021
34032504Real-World Practice Patterns and Predictors of Continuous versus Intermittent Androgen Deprivation Therapy Use for Prostate Cancer in Older Men.J Urol2021
34362709Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework.Eur Urol Focus2021
34134928Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis.Urol Oncol2021
33253640Nadofaragene firadenovec: a new gold standard for BCG-unresponsive bladder cancer?Lancet Oncol2021
33340227Does prophylactic ureteric stenting at the time of colorectal surgery reduce the risk of ureteric injury? A systematic review and meta-analysis.Colorectal Dis2021
33168398Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model.Clin Genitourin Cancer2021
33454930Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature.Oncol Ther2021
  • 1 - 50 of 239

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 2
Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 1
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 2
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 3
David C Johnson
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 4
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 9
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 2
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 1
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 6
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 4
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 8
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 8
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 13
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 3
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 15
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 2
Jim C Hu
Weill Cornell Medical Center
Career Start Year 1998
Number of shared co-authors 8
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 8
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 13
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 9
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 3
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 7
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 9
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 8
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 9
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 10

Collaborators

Neil E Fleshner
University of Toronto
Co-authored papers 107
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 87
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 78
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 31
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 27
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 22
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 18
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 16
David Robert Siemens
Queen's University
Co-authored papers 10
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 8
Muhammad Mamdani
Institute of Health Policy, University of Toronto
Co-authored papers 8
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 8
Katherine Lajkosz
Princess Margaret Hospital
Co-authored papers 7
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 6
Robert G Bristow
University of Toronto
Co-authored papers 5
Fred Saad
University of Montreal Health Center
Co-authored papers 4
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 4
Kyunghoon Lee
Seoul National University Bundang Hospital and College of Medicine
Co-authored papers 4
Joseph L Chin
University of Western Ontario
Co-authored papers 4
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 4
Masoom A Haider
University Health Network
Co-authored papers 4
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 3
Peter J Wild
Co-authored papers 3
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Co-authored papers 3
Ann M Farrell
Mayo Clinic Libraries
Co-authored papers 3
Avery B Nathens
University of Toronto.
Co-authored papers 3
Tristan Juvet
Lions Gate Hospital
Co-authored papers 3
Jethro C C Kwong
University of Toronto
Co-authored papers 3
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 2
Release 1.2